Browse Category

NASDAQ:BBIO 5 January 2026 - 16 January 2026

For live price, interactive charts, financials and the latest market data, visit Google Finance.

BridgeBio Pharma (BBIO) stock edges up after $550 million convertible notes pricing — what investors watch next

Shares of BridgeBio Pharma Inc edged up 0.5% to $76.66 Friday afternoon, following the announcement of a $550 million convertible notes sale. The stock swung between $75.87 and $78.12, with roughly 5.9 million shares changing hands.

16 January 2026

NASDAQ:BBIO·Stock Market

BridgeBio Pharma (BBIO) stock sinks 7% as JPM conference nears and achondroplasia catalyst looms

BridgeBio Pharma shares slid 7.5% to $72.34 in afternoon trading on Monday after opening at $78.44 and touching $79.24 earlier in the session. The drop outpaced a roughly 2.2% decline in the SPDR S&P Biotech ETF, a broad gauge of U.S. biotech stocks.

5 January 2026

Biotechnology·NASDAQ:BBIO·Stock Market

Go toTop